Robert D. Toto
Impact in
- Nephrology top 0.01%
- Dialysis and Renal Disease Management
- Chronic Kidney Disease and Diabetes
-
- Diabetes Treatment and Management
- Hormonal Regulation and Hypertension
Papers in
- Nephrology 129
- Chronic Kidney Disease and Diabetes 61
- Dialysis and Renal Disease Management 48
- Renal Diseases and Glomerulopathies 21
-
- Blood Pressure and Hypertension Studies 79
- Co-authors
- Andrew S. Levey (14 shared papers)George L. Bakris (12 shared papers)Dick de Zeeuw (15 shared papers)John J.V. McMurray (47 shared papers)Tom Greene (28 shared papers)Domenic Sica (3 shared papers)Timothy F. Murphy (3 shared papers)William B. White (3 shared papers)
- Journals
- American Journal of Kidney Diseases (25 papers)Journal of the American Society of Nephrology (21 papers)Kidney International (21 papers)Kidney International Reports (8 papers)Hypertension (8 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Robert D. Toto
243 papers receiving 20.5k citations
Robert D. Toto's Hit Papers
Peers
Comparison fields: 5 of 164
- Nephrology 9.0k
- Endocrinology, Diabetes and Metabolism 5.8k
- Cardiology and Cardiovascular Medicine 8.0k
- Hematology 2.5k
- Emergency Medical Services 866
Countries citing papers authored by Robert D. Toto
This map shows the geographic impact of Robert D. Toto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert D. Toto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert D. Toto more than expected).
Fields of papers citing papers by Robert D. Toto
This network shows the impact of papers produced by Robert D. Toto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert D. Toto. The network helps show where Robert D. Toto may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert D. Toto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 250 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Resistant Hypertension: Diagnosis, Evaluation, and Treatment Hit paper breakdown → | 2008 | 1666 |
| 2 | A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease Hit paper breakdown → | 2009 | 1429 |
| 3 | Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis Hit paper breakdown → | 2002 | 1297 |
| 4 | Preserving renal function in adults with hypertension and diabetes: A consensus approach Hit paper breakdown → | 2000 | 1069 |
| 5 | Resistant Hypertension: Diagnosis, Evaluation, and Treatment Hit paper breakdown → | 2008 | 1004 |
| 6 | Sympathetic Overactivity in Patients with Chronic Renal Failure Hit paper breakdown → | 1992 | 854 |
| 7 | Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease Hit paper breakdown → | 2013 | 784 |
| 8 | Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis Hit paper breakdown → | 2003 | 775 |
| 9 | Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk Hit paper breakdown → | 2018 | 756 |
| 10 | Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes Hit paper breakdown → | 2011 | 707 |
| 11 | 2003 | 418 | |
| 12 | 2004 | 401 | |
| 13 | 2003 | 365 | |
| 14 | Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial Hit paper breakdown → | 2020 | 355 |
| 15 | 2010 | 337 | |
| 16 | 2009 | 290 | |
| 17 | A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy Hit paper breakdown → | 2021 | 237 |
| 18 | 2005 | 218 | |
| 19 | 2012 | 216 | |
| 20 | 2008 | 205 |
About Robert D. Toto
Robert D. Toto is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery and Pulmonary and Respiratory Medicine, having authored 250 papers that have together received 21.2k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (79 papers), Chronic Kidney Disease and Diabetes (61 papers), Diabetes Treatment and Management (55 papers), Dialysis and Renal Disease Management (48 papers), Hormonal Regulation and Hypertension (26 papers), Pancreatic function and diabetes (23 papers), Renal Diseases and Glomerulopathies (21 papers) and Erythropoietin and Anemia Treatment (19 papers). The work is most often cited by research in Nephrology (9.0k citations), Endocrinology, Diabetes and Metabolism (5.8k citations), Cardiology and Cardiovascular Medicine (8.0k citations), Hematology (2.5k citations) and Emergency Medical Services (866 citations). Robert D. Toto has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Andrew S. Levey, George L. Bakris, Dick de Zeeuw, John J.V. McMurray, Tom Greene, Domenic Sica, Timothy F. Murphy, William B. White, Stephen C. Textor and David C. Goff. Their work appears in journals such as American Journal of Kidney Diseases, Journal of the American Society of Nephrology, Kidney International, Kidney International Reports and Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.